Structural Heart

This structural heart channel includings content related to heart valve repair and replacement, left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and occlusion of ASDs, VSDs and PFOs.

Colibri Heart Valve Continues Enrollment in TAVI Early Feasibility Study
News | Heart Valve Technology | May 07, 2018

May 7, 2018 — Colibri Heart Valve LLC announced the Colibri...

An 3D echo view of a Neovasc Tiara transcatheter mitral valve. This valve is currently in clinical trials and is ahead of most of the TMVR devices in development.

A 3-D echo view of a Neovasc Tiara transcatheter mitral valve. This valve is currently in clinical trials and is ahead of most of the TMVR devices in development.

Feature | Heart Valve Technology | May 04, 2018 | Dave Fornell, Editor

May 4, 2018 — Transcatheter...

Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy - Cardioband Tricuspid Valve Reconstruction System
News | Heart Valve Technology | May 01, 2018

May 1, 2018 — Edwards Lifesciences Corp.announced that it received CE Mark for the Edwards Cardioband Tricuspid...

Boston Scientific Prevails in European Patent Dispute With Edwards Lifesciences
News | Heart Valve Technology | April 26, 2018

April 26, 2018 — The European Patent Office (EPO) has revoked Edward Lifesciences’ Corp.’s European patent EP 2,399,...

A CT scan assessment of the femoral access route challenges for a recent Central DuPage Hospital TAVR candidate. This image and the measurements were discussed by the heart team during its weekly meeting to determine if the TAVR delivery catheters could navigate the disease femoral artery and what options might best serve this patient.

A CT scan assessment of the femoral access route challenges for a recent Central DuPage Hospital TAVR candidate. This image and the measurements were discussed by the heart team during its weekly meeting to determine if the TAVR delivery catheters could navigate the disease femoral artery and what options might best serve this patient. 

 

Feature | Heart Valve Technology | April 20, 2018 | Dave Fornell

While there is fear by many about the trend of hospitals consolidating into larger healthcare systems, one advantage...

A transcaval access TAVR procedure, showing a guide wire in the vena cava and a snare located in the aorta to pull the guide wire through.

A transcaval access TAVR procedure, showing a guide wire in the vena cava and a snare located in the aorta to pull the guide wire through.

Feature | Heart Valve Technology | April 19, 2018 | Dave Fornell

Patient selection for who is best suited for a...

University Hospitals Performs Ohio's First Transcatheter Mitral Valve Replacement
News | Heart Valve Technology | April 06, 2018

April 6, 2018 —  University Hospitals Harrington Heart & Vascular Institute has officially opened the APOLLO...

FDA Approves Gore Cardioform Septal Occluder for PFO Closure Prevent Recurrent Ischemic Stroke
Technology | Structural Heart Occluders | April 03, 2018

April 3, 2018 — Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen...

American College of Cardiology, #ACC18

Most of the big stories March 2018 were the late-breaking trial presentations at the American College of Cardiology (ACC) meeting during the month.

Feature | April 02, 2018 | Dave Fornell

Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC)...

LivaNova Announces Enrollment for PERFECT Perceval Valve Clinical Trial in China
News | Heart Valve Technology | March 30, 2018

March 30, 2018 — LivaNova PLC announced the first patient enrollment in the Perceval Valve...

Edwards Completes Enrollment in PARTNER 3 Low-Risk CT Sub-Study
News | Heart Valve Technology | March 27, 2018

March 27, 2018 — Edwards Lifesciences Corp. announced that enrollment is complete in the...

A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell

There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American...

Edwards Lifesciences received European CE mark clearance for its self-expanding Centera transcatheter aortic valve replacement (TAVR) device for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery.

Edwards Lifesciences received European CE mark clearance for its self-expanding Centera transcatheter aortic valve replacement (TAVR) device for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery. This was the top structural heart story of the month of February 2018.

Feature | March 20, 2018 | Dave Fornell

Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC)...

Trial Bolsters Evidence in Favor of Closing Hole in Heart After Stroke
News | ACC | March 20, 2018

March 20, 2018 — Among people with a type of hole in the heart, known as patent foramen ovale (PFO), those who...

Overlay Init